Sir
Generalized granuloma annulare (GGA) is an uncommon variant of granuloma annulare (GA) presenting with multiple asymptomatic or slightly pruritic, skin-colored, or erythematous papules, which may coalesce into annular plaques, occurring on trunk and extremities. Typically, GGA shows a protracted course and poor response to therapy. [1, 2] Hepatitis C virus (HCV) infection may be associated with such disease. [3] We describe the first case of GGA in a HCV antibody-positive cirrhotic patient successfully treated with narrowband ultraviolet B (Nb-UVB) therapy.
A 70-year-old woman with a 8-year history of Child-Pugh class A HCV-related cirrhosis (previously treated unsuccessfully with two cycles of interferon plus ribavirin, the last of which two years earlier) presented with numerous mildly pruritic, partially confluent, pink-reddish papules on the trunk and limbs of 4 months duration [ Figures 1a and b] . The patient denied drug intake or other significant health problems. Routine laboratory examinations showed no alteration except for hypoalbuminemia (2.8 mg/dl) and a slightly prolonged prothrombin time (INR value of 1.7) due to chronic liver failure. Antinuclear antibodies and HIV serology were negative. Histopathology from a papule showed interstitial infiltration of histiocytes and lymphocytes in upper and medium dermis [ Figure 2a ] Colloidal iron stain displayed mucin deposition in reticular dermis [ Figure 2b ]. Therefore, a diagnosis of GGA was made. The patient was treated with Nb-UVB therapy (three times weekly) with a starting dose of 0.35 J/cm 2 and subsequent increments of 10% every session. After 8 weeks the lesions regressed [ Figures 3a and b] , and there was no recurrence after 3 months of follow-up. No side-effects were observed.
Although many anecdotal therapies have been used with varying degrees of success in the treatment of GGA, [1] the literature supports the use of isotretinoin, dapsone and phototherapy with oral psoralen and ultraviolet A (PUVA) as first-line options. [2] However, these therapies may be associated with significant side-effects and are notoriously contraindicated in patients with liver impairment, as in our case.
Bath-PUVA with sun exposure (PUVASOL) [2] and Nb-UVB therapy [3] [4] [5] are reported to be efficacious in GGA and could be considered as ultraviolet-based alternatives to PUVA therapy for patients with hepatic failure since they don't require oral psoralen administration and present a good safety profile. [2] [3] [4] [5] Regarding Nb-UVB therapy, 
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Inui et al. reported a case of GGA (previously resistant to topical steroids and tacrolimus) resulting in resolution after 24 sessions, [3] while Yashar et al. described another instance with "minimal to mild" response (treatment regimen, duration, patient compliance and satisfaction were not indicated). [4] Moreover, Nb-UVB has also been successfully used as adjuvant therapy with insulin and oral tranilast in a case of eruptive GGA. [3] Albeit the mechanism by which NB-UVB acts upon GA is not completely clear, it is thought that it is able to reduce the lymphoproliferation and cytokine production, thus counteracting granuloma formation. [4] In conclusion, our case confirms the efficacy of Nb-UVB therapy in GGA and emphasizes its utility in patients with chronic liver failure, in which first-line treatments are contraindicated. Anyhow, further studies are needed to confirm these assumptions.
